Run Cui, Hao Duan, Wanming Hu, Chang Li, Sheng Zhong, Lun Liang, Siyu Chen, Hongrong Hu, Zhenqiang He, Zhenning Wang, Xiaoyu Guo, Zexin Chen, Cong Xu, Yu Zhu, Yinsheng Chen, Ke Sai, Qunying Yang, Chengcheng Guo, Yonggao Mou, Xiaobing Jiang
CONTEXT: Precision medicine for pituitary neuroendocrine tumors (PitNETs) is limited by the lack of reliable research models. OBJECTIVE: To generate patient-derived organoids (PDOs), which could serve as a platform for personalized drug screening for PitNET patients. DESIGN: From July 2019 to May 2022, a total of 32 human PitNET specimens were collected for the establishment of organoids with an optimized culture protocol. SETTING: This study was conducted at Sun Yat-Sen University Cancer Center...
April 24, 2024: Journal of Clinical Endocrinology and Metabolism